T26

Q3 Medicine
Z. Pranjol , N. Gutowski , M. Hannemann , J. Whatmore
{"title":"T26","authors":"Z. Pranjol ,&nbsp;N. Gutowski ,&nbsp;M. Hannemann ,&nbsp;J. Whatmore","doi":"10.1016/j.ejcsup.2015.08.078","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Epithelial ovarian cancer frequently metastasizes to the omentum, a process that requires pro-angiogenic activation of HOMECs by tumour -secreted factors in their microenvironment. We have previously shown that ovarian cancer cells secrete a range of factors with possible roles in metastatic angiogenesis including the lysosomal proteases cathepsin D (CD) and cathepsin L (CL). However, the role of these proteases in ovarian cancer metastasis to the omentum is not fully understood.</p></div><div><h3>Aim</h3><p>To investigate whether proliferative effects of CD and CL are dependent on their catalytic activity in HOMECs.</p><p>To investigate the intracellular signalling kinases activated by CD and CL.</p></div><div><h3>Method</h3><p>HOMEC proliferation was assessed by using a colorimetric (WST1) assay. Potential signalling pathways were examined by phosphokinase array and ELISAs. pH experiments were carried out examine whether the observed effects were due to the catalytic activity of CD and CL.</p></div><div><h3>Result</h3><p>CD and CL (50<!--> <!-->ng/ml) significantly increased HOMEC proliferation to 141<!--> <!-->±<!--> <!-->27% (<em>p</em> <!-->=<!--> <!-->0.001, <em>n</em> <!-->=<!--> <!-->50) and 151%<!--> <!-->±<!--> <!-->34% (<em>p</em> <!-->=<!--> <!-->0.001, <em>n</em> <!-->=<!--> <!-->45) respectively vs. control (100%) 72<!--> <!-->h post-treatment. Inhibitors of CD and CL enzyme activity had no effect on HOMEC proliferation and subsequent pH data suggest a nonproteolytic mitogenic activity of these cathepsins. Both proteins induced phosphorylation of ERK1/2, AKT and p38<em>α</em> to ∼2, ∼1.5 and ∼1.5 folds respectively relative to total levels (compared to control).</p></div><div><h3>Conclusion</h3><p>CD and CL induced proliferation in HOMECs. CD and CL may non- proteolytically contribute to pro-angiogenic responses of the omental microvasculature. Induction of phosphorylation of proliferative kinases ERK1/2, AKT and p38<em>α</em> suggest possible downstream signalling cascades of these proteins.</p></div>","PeriodicalId":11675,"journal":{"name":"Ejc Supplements","volume":"13 1","pages":"Page 44"},"PeriodicalIF":0.0000,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejcsup.2015.08.078","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejc Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359634915000798","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Background

Epithelial ovarian cancer frequently metastasizes to the omentum, a process that requires pro-angiogenic activation of HOMECs by tumour -secreted factors in their microenvironment. We have previously shown that ovarian cancer cells secrete a range of factors with possible roles in metastatic angiogenesis including the lysosomal proteases cathepsin D (CD) and cathepsin L (CL). However, the role of these proteases in ovarian cancer metastasis to the omentum is not fully understood.

Aim

To investigate whether proliferative effects of CD and CL are dependent on their catalytic activity in HOMECs.

To investigate the intracellular signalling kinases activated by CD and CL.

Method

HOMEC proliferation was assessed by using a colorimetric (WST1) assay. Potential signalling pathways were examined by phosphokinase array and ELISAs. pH experiments were carried out examine whether the observed effects were due to the catalytic activity of CD and CL.

Result

CD and CL (50 ng/ml) significantly increased HOMEC proliferation to 141 ± 27% (p = 0.001, n = 50) and 151% ± 34% (p = 0.001, n = 45) respectively vs. control (100%) 72 h post-treatment. Inhibitors of CD and CL enzyme activity had no effect on HOMEC proliferation and subsequent pH data suggest a nonproteolytic mitogenic activity of these cathepsins. Both proteins induced phosphorylation of ERK1/2, AKT and p38α to ∼2, ∼1.5 and ∼1.5 folds respectively relative to total levels (compared to control).

Conclusion

CD and CL induced proliferation in HOMECs. CD and CL may non- proteolytically contribute to pro-angiogenic responses of the omental microvasculature. Induction of phosphorylation of proliferative kinases ERK1/2, AKT and p38α suggest possible downstream signalling cascades of these proteins.

T26
上皮性卵巢癌经常转移到网膜,这一过程需要肿瘤分泌因子在其微环境中激活homec的促血管生成。我们之前已经证明卵巢癌细胞分泌一系列可能在转移性血管生成中起作用的因子,包括溶酶体蛋白酶组织蛋白酶D (CD)和组织蛋白酶L (CL)。然而,这些蛋白酶在卵巢癌大网膜转移中的作用尚不完全清楚。目的探讨CD和CL在HOMECs中的增殖作用是否依赖于它们的催化活性。探讨CD和CL对细胞内信号激酶的激活作用。方法采用比色法(WST1)检测细胞增殖。通过磷酸激酶阵列和elisa检测潜在的信号通路。进行了pH实验,以检验所观察到的效果是否由CD和CL的催化活性引起。结果cd和CL (50 ng/ml)处理72 h后,与对照组(100%)相比,分别使HOMEC增殖141±27% (p = 0.001, n = 50)和151%±34% (p = 0.001, n = 45)。CD和CL酶活性抑制剂对HOMEC增殖没有影响,随后的pH数据表明这些组织蛋白酶具有非蛋白溶解性有丝分裂活性。两种蛋白均诱导ERK1/2、AKT和p38α的磷酸化水平相对于总水平分别达到2倍、1.5倍和1.5倍(与对照组相比)。结论cd和CL可诱导HOMECs细胞增殖。CD和CL可能非蛋白性地促进大网膜微血管的促血管生成反应。诱导增殖激酶ERK1/2、AKT和p38α的磷酸化提示这些蛋白可能存在下游信号级联反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ejc Supplements
Ejc Supplements 医学-肿瘤学
自引率
0.00%
发文量
0
审稿时长
3.7 months
期刊介绍: EJC Supplements is an open access companion journal to the European Journal of Cancer. As an open access journal, all published articles are subject to an Article Publication Fee. Immediately upon publication, all articles in EJC Supplements are made openly available through the journal''s websites. EJC Supplements will consider for publication the proceedings of scientific symposia, commissioned thematic issues, and collections of invited articles on preclinical and basic cancer research, translational oncology, clinical oncology and cancer epidemiology and prevention. Authors considering the publication of a supplement in EJC Supplements are requested to contact the Editorial Office of the EJC to discuss their proposal with the Editor-in-Chief. EJC Supplements is an official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO) and the European Society of Mastology (EUSOMA).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信